Quantum Biopharma (QNTM) Research & Development (2020 - 2026)
Quantum Biopharma's Research & Development was $387,428 in Q2 2026, down 29.5% from $549,197 a year earlier and down 38.1% from the prior quarter.
Quantum Biopharma (QNTM) Research & Development (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Quantum Biopharma's Research & Development was $1.58 million through Jun 30, 2026, down 49.1% year-over-year; for FY2025, it was $2.76 million, down 54.6% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -18.8% (FY2020 to FY2025).
- In earlier years, Research & Development was $6.08 million in FY2024 (+57.6%), $3.86 million in FY2023 (-44.2%), $6.91 million in FY2022 (+9.2%) and $6.33 million in FY2021 (-19.2%).
- Quarterly Research & Development has moved between -$107,258 (Q3 2021) and $2.69 million (Q4 2022) over five years.
- Compared with a year earlier, Research & Development has declined for four straight quarters, with growth averaging 109.6% over the last six quarters.
- The best year-over-year quarter for Research & Development over five years was Q1 2025 (growth of 928.5%); the worst was Q3 2023 (a decline of 98.2%).
- Per Business Quant data, QNTM's Research & Development in the three quarters before Q2 2026 was $626,092 (Q1 2026), $70,404 (Q4 2025) and $495,223 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Quantum Biopharma | 15.40 Mn | 3.20 Mn | - | 387,428.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 387,428.00 |
| Mar 31, 2026 | 626,092.00 |
| Dec 31, 2025 | 70,404.00 |
| Sep 30, 2025 | 495,223.00 |
| Jun 30, 2025 | 549,197.00 |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 160,260.00 |
| Sep 30, 2024 | 744,802.00 |
| Mar 31, 2024 | 160,260.00 |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 32,985.00 |
| Mar 31, 2023 | 2.31 Mn |
| Dec 31, 2022 | 2.69 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 937,052.00 |
| Dec 31, 2021 | 852,393.00 |
| Sep 30, 2021 | -107,258.00 |
| Jun 30, 2021 | 3.61 Mn |
| Mar 31, 2021 | 1.97 Mn |
Quantum Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=QNTM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "QNTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=QNTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();